Advanced search
Publication Cover
Acta Oncologica Volume 52, 2013 - Issue 4
Journal homepage
1,472
Views
24
CrossRef citations to date
0
Altmetric
Letters to the Editor

GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients

Troels K. BergmannSchool of Pharmacy, University of Queensland, Brisbane, Australia;Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Odense, DenmarkCorrespondence[email protected]
,
Werner VachClinical Epidemiology, Institute of Medical Biometry and Medical Informatics, University Medical Center, Freiburg, Germany
,
Søren FeddersenDepartment of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark
,
Lise EckhoffDepartment of Oncology, Odense University Hospital, Odense, Denmark
,
Henrik GréenClinical Pharmacology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden;Science for Life Laboratory, School of Biotechnology, Division of Gene Technology, Royal Institute of Technology, Solna, Sweden
,
Jørn HerrstedtDepartment of Oncology, Odense University Hospital, Odense, Denmark
&
Kim BrosenClinical Pharmacology, Institute of Public Health, University of Southern Denmark, Odense, Denmark
 show all
Pages 871-873 | Received 06 May 2012, Accepted 21 Jun 2012, Published online: 09 Aug 2012

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zeina N. Al-Mahayri, Mohammad M. AlAhmad & Bassam R. Ali. (2021) Current opinion on the pharmacogenomics of paclitaxel-induced toxicity. Expert Opinion on Drug Metabolism & Toxicology 17:7, pages 785-801.
Read now
Amit A. Kulkarni, Ganesh Boora, Rahul Kanwar, Kathryn J. Ruddy, Michaela S. Banck, Nguyet Le-Lindqwister, Terry M. Therneau, Charles L. Loprinzi & Andreas S. Beutler. (2015) RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1. Acta Oncologica 54:8, pages 1227-1229.
Read now

Articles from other publishers (22)

Anukriti Sharma, Ken B. Johnson, Bihua Bie, Emily E. Rhoades, Alper Sen, Yuri Kida, Jennifer Hockings, Alycia Gatta, Jacqueline Davenport, Connie Arcangelini, Jennifer Ritzu, Jennifer DeVecchio, Ron Hughen, Mei Wei, G. Thomas Budd, N. Lynn Henry, Charis Eng, Joseph Foss & Daniel M. Rotroff. (2022) A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol. Technology in Cancer Research & Treatment 21, pages 153303382211271.
Crossref
Zahra Talebi, Alex Sparreboom & Susan I. Colace. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 63 94 .
Daniel L. Hertz, Cindy Tofthagen & Sara Faithfull. 2021. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 19 51 .
Nathan P. Staff, Jill C. Fehrenbacher, Martial Caillaud, M. Imad Damaj, Rosalind A. Segal & Sandra Rieger. (2020) Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Experimental Neurology 324, pages 113121.
Crossref
Jason T. Anderson, Kevin M. Huang, Maryam B. Lustberg, Alex Sparreboom & Shuiying Hu. 2022. Targets of Cancer Diagnosis and Treatment. Targets of Cancer Diagnosis and Treatment 177 215 .
Alexandre Chan, Daniel L. Hertz, Manuel Morales, Elizabeth J. Adams, Sharon Gordon, Chia Jie Tan, Nathan P. Staff, Jayesh Kamath, Jeong Oh, Shivani Shinde, Doreen Pon, Niharkia Dixit, James D’Olimpio, Cristina Dumitrescu, Margherita Gobbo, Kord Kober, Samantha Mayo, Linda Pang, Ishwaria Subbiah, Andreas S. Beutler, Katherine B. Peters, Charles Loprinzi & Maryam B. Lustberg. (2019) Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Supportive Care in Cancer 27:10, pages 3729-3737.
Crossref
Rafid Salim Jabir, Gwo Fuang Ho, Muhammad Azrif Bin Ahmad Annuar & Johnson Stanslas. (2018) Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients. Clinical Breast Cancer 18:5, pages e1173-e1179.
Crossref
Annelot G.J. van Rossum, Marleen Kok, Danielle McCool, Mark Opdam, Nienke C. Miltenburg, Ingrid A.M. Mandjes, Elise van Leeuwen-Stok, Alex L.T. Imholz, Johanneke E.A. Portielje, Monique M.E.M. Bos, Aart van Bochove, Erik van Werkhoven, Marjanka K. Schmidt, Hendrika M. Oosterkamp & Sabine C. Linn. (2017) Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy. Oncotarget 8:69, pages 113531-113542.
Crossref
Joana Assis, Carina Pereira, Augusto Nogueira, Deolinda Pereira, Rafael Carreira & Rui Medeiros. (2017) Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer Treatment Reviews 61, pages 35-52.
Crossref
J. Cliff, A.L. Jorgensen, R. Lord, F. Azam, L. Cossar, D.F. Carr & M. Pirmohamed. (2017) The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 120, pages 127-140.
Crossref
Nathan P. Staff, Anna Grisold, Wolfgang Grisold & Anthony J. Windebank. (2017) Chemotherapy-induced peripheral neuropathy: A current review. Annals of Neurology 81:6, pages 772-781.
Crossref
Yonghe Wu, Lucas Tedesco, Kristin Lucia, Anna M. Schlitter, Jose Monteserin Garcia, Irene Esposito, Christoph J. Auernhammer, Marily Theodoropoulou, Eduardo Arzt, Ulrich Renner & Günter K. Stalla. (2016) RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors. Oncotarget 7:36, pages 57878-57893.
Crossref
C.N. Frederiks, S.W. Lam, H.J. Guchelaar & E. Boven. (2015) Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review. Cancer Treatment Reviews 41:10, pages 935-950.
Crossref
Ganesh K. Boora, Amit A. Kulkarni, Rahul Kanwar, Peter Beyerlein, Rui Qin, Michaela S. Banck, Kathryn J. Ruddy, Josef Pleticha, Cynthia A. Lynch, Robert J. Behrens, Stephan Züchner, Charles L. Loprinzi & Andreas S. Beutler. (2015) Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). Journal of the Neurological Sciences 357:1-2, pages 35-40.
Crossref
J Gerez, L Tedesco, J J Bonfiglio, M Fuertes, M Barontini, S Silberstein, Y Wu, U Renner, M Páez-Pereda, F Holsboer, G K Stalla & E Arzt. (2014) RSUME inhibits VHL and regulates its tumor suppressor function. Oncogene 34:37, pages 4855-4866.
Crossref
Cielito C. Reyes-Gibby, Jian Wang, Sai-Ching J. Yeung & Sanjay Shete. (2015) Informative gene network for chemotherapy-induced peripheral neuropathy. BioData Mining 8:1.
Crossref
Edgardo Rivera & Mary Cianfrocca. (2015) Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemotherapy and Pharmacology 75:4, pages 659-670.
Crossref
Aparna Chhibber, Deanna L Kroetz, Kelan G Tantisira, Michael McGeachie, Cheng Cheng, Robert Plenge, Eli Stahl, Wolfgang Sadee, Marylyn D Ritchie & Sarah A Pendergrass. (2014) Genomic architecture of pharmacological efficacy and adverse events. Pharmacogenomics 15:16, pages 2025-2048.
Crossref
Ewelina Rojewska, Michal Korostynski, Ryszard Przewlocki, Barbara Przewlocka & Joanna Mika. (2014) Expression Profiling of Genes Modulated by Minocycline in a Rat Model of Neuropathic Pain. Molecular Pain 10, pages 1744-8069-10-47.
Crossref
A Chhibber, J Mefford, E A Stahl, S A Pendergrass, R M Baldwin, K Owzar, M Li, E P Winer, C A Hudis, H Zembutsu, M Kubo, Y Nakamura, H L McLeod, M J Ratain, L N Shulman, M D Ritchie, R M Plenge, J S Witte & D L Kroetz. (2014) Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). The Pharmacogenomics Journal 14:4, pages 336-342.
Crossref
Daniel L Hertz. (2013) Germline pharmacogenetics of paclitaxel for cancer treatment. Pharmacogenomics 14:9, pages 1065-1084.
Crossref
Anne-Joy M. de Graan, Laure Elens, Jason A. Sprowl, Alex Sparreboom, Lena E. Friberg, Bronno van der Holt, Pleun J. de Raaf, Peter de Bruijn, Frederike K. Engels, Ferry A.L.M. Eskens, Erik A.C. Wiemer, Jaap Verweij, Ron H.J. Mathijssen & Ron H.N. van Schaik. (2013) CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity . Clinical Cancer Research 19:12, pages 3316-3324.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.